Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KLF5 promotes the ossification process of ligamentum flavum by transcriptionally activating CX43. | J Orthop Surg Res | 2024 | 38622696 | PubTator, text mining | PubMed |
| Machine-learning analysis reveals an important role for negative selection in shaping cancer aneuploidy landscapes. | Genome Biol | 2024 | 38622679 | PubTator, text mining | PubMed |
| Depression of LncRNA DANCR alleviates tubular injury in diabetic nephropathy by regulating KLF5 through sponge miR-214-5p. | BMC Nephrol | 2024 | 38609873 | PubTator, text mining | PubMed |
| Comprehensive analysis of immunogenic cell death-related gene and construction of prediction model based on WGCNA and multiple machine learning in severe COVID-19. | Sci Rep | 2024 | 38600309 | PubTator, text mining | PubMed |
| [Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma]. | Zhonghua Gan Zang Bing Za Zhi | 2024 | 38514264 | PubTator, text mining | PubMed |
| Editorial Expression of Concern: HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs. | Cell Res | 2024 | 38491171 | PubTator, text mining | PubMed |
| Morroniside improves AngII-induced cardiac fibroblast proliferation, migration, and extracellular matrix deposition by blocking p38/JNK signaling pathway through the downregulation of KLF5. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38472369 | PubTator, text mining | PubMed |
| Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer. | Cancer Lett | 2024 | 38471646 | PubTator, text mining | PubMed |
| UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5. | Breast Cancer Res | 2024 | 38468288 | PubTator, text mining | PubMed |
| Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38433576 | PubTator, text mining | PubMed |
| Activation of the YAP/KLF5 transcriptional cascade in renal tubular cells aggravates kidney injury. | Mol Ther | 2024 | 38414248 | PubTator, text mining | PubMed |
| Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma. | Oncogene | 2024 | 38409551 | PubTator, text mining | PubMed |
| Statement of Retraction: Testis developmental related gene 1 promotes non-small-cell lung cancer through the microRNA-214-5p/Krüppel-like factor 5 axis. | Bioengineered | 2024 | 38376413 | PubTator, text mining | PubMed |
| Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer. | Exp Ther Med | 2024 | 38361511 | PubTator, text mining | PubMed |
| Gene expression analysis reveals diabetes-related gene signatures. | Hum Genomics | 2024 | 38326874 | PubTator, text mining | PubMed |
| Dapagliflozin improves podocytes injury in diabetic nephropathy via regulating cholesterol balance through KLF5 targeting the ABCA1 signalling pathway. | Diabetol Metab Syndr | 2024 | 38326870 | PubTator, text mining | PubMed |
| Unraveling molecular similarities between colorectal polyps and colorectal cancer: a systems biology approach. | Intest Res | 2024 | 38311712 | PubTator, text mining | PubMed |
| MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage. | Biomark Res | 2024 | 38308370 | PubTator, text mining | PubMed |
| Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis. | Genome Med | 2024 | 38297291 | PubTator, text mining | PubMed |
| Breaking paradigms: Long non-coding RNAs forming gene fusions with potential implications in cancer. | Genes Dis | 2024 | 38292185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=14